Characterization and biologic activities of an anti-idiotype-specific T cell line and its derived clonesMOZES, E; ZINGER, H.The Journal of immunology (1950). 1987, Vol 139, Num 11, pp 3564-3569, issn 0022-1767Article

Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE) ; clinical benefits associated with cytokine manipulationSEGAL, R; DAYAN, M; ZINGER, H et al.Clinical and experimental immunology (Print). 1995, Vol 101, Num 1, pp 66-72, issn 0009-9104Article

The influence of aging on the induction and manifestations of experimental systemic lupus erythematosusSEGAL, R; GLOBERSON, A; ZINGER, H et al.Journal of clinical immunology. 1992, Vol 12, Num 5, pp 341-346, issn 0271-9142Article

Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patientsMAUERMANN, N; STHOEGER, Z; ZINGER, H et al.Clinical and experimental immunology (Print). 2004, Vol 137, Num 3, pp 513-520, issn 0009-9104, 8 p.Article

Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibodyEILAT, E; ZINGER, H; NYSKA, A et al.Journal of clinical immunology. 2000, Vol 20, Num 4, pp 268-278, issn 0271-9142Article

Induction of experimental systemic lupus erythematosus in mice by immunization with the F(ab')₂ fragment of the human anti-DNA monoclonal antibody carrying the 16/6 idiotypeRUIZ, P. J; ZINGER, H; MOZES, E et al.Immunology letters. 1994, Vol 41, Num 1, pp 79-84, issn 0165-2478Article

Spontaneous autoimmune disease in (NZB X NZW)F₁ mice is ameliorated by treatment with methimazoleMOZES, E; ZINGER, H; KOHN, L. D et al.Journal of clinical immunology. 1998, Vol 18, Num 2, pp 106-113, issn 0271-9142Article

The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosusWAISMAN, A; MENDLOVIC, S; RUIZ, P. J et al.International immunology. 1993, Vol 5, Num 10, pp 1293-1300, issn 0953-8178Article

Regulatory T cell activity specific to human type II and III collagens in rheumtoid arthritisELKAYAM, O; ZINGER, H; ZISMAN, E et al.Journal of rheumatology. 1991, Vol 18, Num 4, pp 516-521, issn 0315-162X, 6 p.Article

Genetic analysis of experimentally induced lupus in miceMOZES, E; ALLING, D; MILLER, M. W et al.Clinical immunology and immunopathology (Print). 1997, Vol 85, Num 1, pp 28-34, issn 0090-1229Article

Autoantibodies to a NR2A peptide of the glutamate/ NMDA receptor in sera of patients with systemic lupus erythematosusHUSEBYE, E. S; STHOEGER, Z. M; DAYAN, M et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 8, pp 1210-1213, issn 0003-4967, 4 p.Article

Modulation of experimental systemic lupus erythematosusMOZES, E; SEGAL, R; STHOEGER, Z et al.Israel journal of medical sciences. 1996, Vol 32, Num 1, pp 19-21, issn 0021-2180Conference Paper

Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cellsLEV-ARI, S; ZINGER, H; KAZANOV, D et al.Biomedicine & pharmacotherapy. 2005, Vol 59, pp S276-S280, issn 0753-3322, SUP2Conference Paper